相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective immunity by an engineered DNA vaccine for Mayaro virus
Hyeree Choi et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Polymorphisms in IL36G gene are associated with plaque psoriasis
Tanel Traks et al.
BMC MEDICAL GENETICS (2019)
Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis
Barbara Meier-Schiesser et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
IL-36 cytokines in autoimmunity and inflammatory disease
Liping Ding et al.
ONCOTARGET (2018)
IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms
Akash H. Verma et al.
JOURNAL OF IMMUNOLOGY (2018)
IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop
Yuriko Hashiguchi et al.
JOURNAL OF IMMUNOLOGY (2018)
Unopposed IL-36 Activity Promotes Clonal CD4(+) T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis
Akiko Arakawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis
Jameson K. Gardner et al.
CYTOKINE (2018)
Systems analysis of human vaccine adjuvants
Ali M. Harandi
SEMINARS IN IMMUNOLOGY (2018)
Interleukin 30 to Interleukin 40
Jovani Catalan-Dibene et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
From discovery to licensure, the Adjuvant System story
Nathalie Garcon et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis
Wenming Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
Andrew Johnston et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and - negative bacterial pneumonia
M. A. Kovach et al.
MUCOSAL IMMUNOLOGY (2017)
Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ
Joseph S. Ainscough et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target
Satveer K. Mahil et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses
Katelynn A. Milora et al.
SCIENTIFIC REPORTS (2017)
A critical appraisal of Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus
Tehmina Bharucha et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2
Tetsuji Aoyagi et al.
PLOS PATHOGENS (2017)
IL-36 cytokines are increased in acne and hidradenitis suppurativa
Roberta Di Caprio et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2017)
A novel mutation in IL36RN underpins childhood pustular dermatosis
J. M. Ellingford et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease
M. -A. Boutet et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
Damien Dietrich et al.
CYTOKINE (2016)
Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines
Conor M. Henry et al.
CELL REPORTS (2016)
IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells
Sean M. Winkle et al.
FRONTIERS IN MICROBIOLOGY (2016)
Alum: an old dog with new tricks
Yumei Wen et al.
EMERGING MICROBES & INFECTIONS (2016)
Production of biologically active IL-36 family cytokines through insertion of N-terminal caspase cleavage motifs
Danielle M. Clancy et al.
FEBS OPEN BIO (2016)
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
Karuppiah Muthumani et al.
NPJ VACCINES (2016)
IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses
Xuefeng Wang et al.
CANCER CELL (2015)
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates
Megan C. Wise et al.
JOURNAL OF VIROLOGY (2015)
Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
Veronica L. Scott et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB/c mice
Karen K. Yam et al.
FRONTIERS IN IMMUNOLOGY (2015)
IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
Alexander M. Foster et al.
JOURNAL OF IMMUNOLOGY (2014)
eInterleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38
Gaelle Clavel et al.
JOINT BONE SPINE (2013)
Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis
Nobuo Kanazawa et al.
JOURNAL OF DERMATOLOGY (2013)
Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
Spyros A. Kalams et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Vaccine adjuvant formulations: A pharmaceutical perspective
Luis A. Brito et al.
SEMINARS IN IMMUNOLOGY (2013)
Overview of the interleukin-1 family of ligands and receptors
Charles A. Dinarello
SEMINARS IN IMMUNOLOGY (2013)
Biology of IL-36 cytokines and their role in disease
Mark S. Gresnigt et al.
SEMINARS IN IMMUNOLOGY (2013)
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells
Solenne Vigne et al.
BLOOD (2012)
IL-36 in psoriasis
J. E. Towne et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2012)
Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk
Luigi Tortola et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii
Kamy Hosseinian Khosroshahi et al.
PARASITOLOGY RESEARCH (2012)
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
Spyros A. Kalams et al.
PLOS ONE (2012)
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques
Rashmi Jalah et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
IL-36R ligands are potent regulators of dendritic and T cells
Solenne Vigne et al.
BLOOD (2011)
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
Govind Ragupathi et al.
EXPERT REVIEW OF VACCINES (2011)
Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
Jennifer E. Towne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
Timo Vesikari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine
Jian Yan et al.
VACCINE (2011)
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity
Sandra Morel et al.
VACCINE (2011)
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Molecular and cellular signatures of human vaccine adjuvants
F. Mosca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond
Amit Lahiri et al.
VACCINE (2008)
How do adjuvants work? Important considerations for new generation adjuvants
Amy S. Mckee et al.
IMMUNITY (2007)
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
Siew-Yen Chong et al.
VACCINE (2007)
The utility of ISCOMATRIX™ adjuvant for dose reduction of antigen for vaccines requiring antibody responses
Jeff Boyle et al.
VACCINE (2007)
Immunogenicity testing of a novel engineered HIV-1 envelope Gp140 DNA vaccine construct
Sanjeev Kumar et al.
DNA AND CELL BIOLOGY (2006)
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques
JD Boyer et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2005)
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-κB and MAPKs
JE Towne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein
L Deml et al.
JOURNAL OF VIROLOGY (2001)
Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL-1 receptor-related protein 2
R Debets et al.
JOURNAL OF IMMUNOLOGY (2001)
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
A Podda
VACCINE (2001)
Identification and initial characterization of four novel members of the interleukin-1 family
S Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Four new members expand the interleukin-1 superfamily
DE Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
